Consequently, HMGCR transcripts were reduced both in the xenograft-derived tumor cells as well as in the original patient tumors indicating that in vivo differentiation of BCSCs reduces HMGCR both in mouse models and in patients (Supplementary Fig. S6). Here, HMGCR is linked to neoplasm.